tumor cell line การใช้

• It is produced by certain tumor cell lines and by macrophages.
• Derivatives of this compound have antitumor activities against sarcoma tumor cell lines.
• Syndecans act as tumor inhibitors by preventing cellular proliferation of tumor cell lines.
• Moreover, CAR expression is not found in normal or tumor cell lines.
• Expression of RGS17 is required for maintenance of proliferation in lung tumor cell lines.
• For example, LONP1 expression levels are increased in different tumors and tumor cell lines.
• Numerous studies have demonstrated that GSH can be differently manipulated in normal versus tumor cell line.
• Phenylahistin is a microtubule binding agent that exhibits cytotoxic activities against a wide variety of tumor cell lines.
• Dependent upon the method of GSH manipulation protection could be demonstrated in normal but not in tumor cell line.
• Increased expression of Sema3A is associated with schizophrenia and is seen in a variety of human tumor cell lines.
• Arglabin and its derivatives are biologically active and demonstrate promising antitumor activity and cytoxocity against varying tumor cell lines.
• However, in human granulosa-like tumor cell line ( KGN ), treatment with FSH increased BMPR2 expression.
• In both human normal and tumor cell lines, YPEL3 has been shown to be a p53-inducible gene.
• Studies have shown that it has " in vitro " against a variety of different tumor cell lines.
• The addition of DLC1 to tumor cells lines which are deficient in DLC1 expression reduces the migration, and increased apoptosis.
• One common way to solve this is to use thymidine kinase negative ( TK " ) tumor cell lines for the fusion.
• SLC45A3 is expressed in a prostate-specific manner by normal tissues and at a significantly lower level in prostate tumor cell lines.
• The inhibition of the PI3K / mTOR pathway has been shown to potently block proliferation by inducing G1 arrest in different tumor cell lines.
• Ligase I has also been found to be upregulated in proliferating tumor cells, as opposed to benign tumor cell lines and normal human cells.
• These studies led to the potent anti-tumor agent plinabulin, which is active in multidrug-resistant ( MDR ) tumor cell lines.